(GRTX) – Corporate News
-
Galera Therapeutics (GRTX) says FDA reiterated need for additional Phase 3 trial of avasopasem manganese for radiotherapy-induced SOM
-
Galera Therapeutics (GRTX) Schedules Type A Meeting with FDA
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GRTX Stock Lookup